39 results
8-K
EX-4.1
INM
InMed Pharmaceuticals Inc
27 Oct 23
Entry into a Material Definitive Agreement
7:16pm
.
Section 5. Miscellaneous.
a) No Rights as Stockholder Until Exercise; No Settlement in Cash. This Warrant does not entitle the Holder to any voting rights, dividends
8-K
EX-4.3
INM
InMed Pharmaceuticals Inc
27 Oct 23
Entry into a Material Definitive Agreement
7:16pm
Investment Option does not entitle the Holder to any voting rights, dividends or other rights as a stockholder of the Company prior to the exercise hereof
8-K
EX-4.2
INM
InMed Pharmaceuticals Inc
27 Oct 23
Entry into a Material Definitive Agreement
7:16pm
as Stockholder Until Exercise; No Settlement in Cash. This Preferred Investment Option does not entitle the Holder to any voting rights, dividends
8-K
EX-4.3
INM
InMed Pharmaceuticals Inc
21 Nov 22
InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market
7:02pm
Investment Option does not entitle the Holder to any voting rights, dividends or other rights as a shareholder of the Company prior to the exercise hereof
8-K
EX-4.1
qfu07jzc4qbhee
21 Nov 22
InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market
7:02pm
8-K
EX-4.2
66b d16hst
21 Nov 22
InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market
7:02pm
8-K
EX-4.3
yqv96di7nc giu
13 Sep 22
InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market
9:59pm
8-K
EX-4.2
7f1s7gqqr2ndo
13 Sep 22
InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market
9:59pm
8-K
EX-4.1
7x6tdjwa3 7paf
13 Sep 22
InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market
9:59pm
8-K
EX-4.2
zt5xj4 bl
3 Jun 22
Entry into a Material Definitive Agreement
9:51pm
8-K
EX-4.1
0njz4fh7s9 xxq2mxao
3 Jun 22
Entry into a Material Definitive Agreement
9:51pm
8-K
EX-4.3
48tcf
3 Jun 22
Entry into a Material Definitive Agreement
9:51pm
424B5
wji6p4e
3 Jun 22
Prospectus supplement for primary offering
9:45pm
424B3
g4mpnf awnb
25 Apr 22
Prospectus supplement
5:02pm
424B3
9jzyumwx1nkzz7 ey1
7 Apr 22
Prospectus supplement
4:46pm
S-3
zopisx6yg8wgf
4 Feb 22
Shelf registration
4:36pm
DEF 14A
lap4s6
28 Oct 21
Definitive proxy
3:07pm